- Details
- Description
Packaging Size:
250mg*30Tablets/Bottle
Strength:
250mg
Composition:
Gefitinib
Treatment:
EGFR Lung Cancer(NSCLC)
Form:
Tablet
Brand:
Geifoni
Quantity Unit:
30Tablets/Bottle
Manufacturer:
Tongmeng (Lao) Pharmaceutical & Food Co., Ltd.(TLPH)
[Indications]
Giefoni is a tyrosine kinase inhibitor (TKI) used in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) where epidermal growth factor receptor (EGFR) exon 19 is absent or exon 21 (L858R) replaces the mutant type.
Medication limitations: the safety and efficacy of Giefoni for EGFR mutations other than exon 19 deletion or exon 21 (L858R) replacement mutations have not been determined
[How to take the drug]
1. Therapy period
Recommended dosage: 250mg, taken orally, once daily; Not with food or with food.
2. Dosage form specification:
- Tablet, 250mg.
